Nébié Issa OUEDRAOGO

Dr. Nébié Issa OUEDRAOGO

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
SSSodiomon Sirima
Sodiomon Sirima
AOAlphonse Ouédraogo
Alphonse Ouédraogo
BTB. Alfred Tiono
B. Alfred Tiono
JKJean Moise T. Kabore
Jean Moise T. Kabore
EBEdith C. Bougouma
Edith C. Bougouma
MLMatthew Laurens
Matthew Laurens
A highly effective malaria vaccine remains elusive despite decades of research. Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), a metabolically active, nonreplicating, whole parasite vaccine demonstrated safety and vaccine efficacy (VE) against endemic P. falciparum for 6 months in Malian adults receiving a five-dose regimen. Safety, immunogenicity, and VE of a three-dose regimen were assessed in adults in Balonghin, Burkina Faso in a two-component study: an open-label dose escalation trial with 32 participants followed by a double-blind, randomized, placebo-controlled trial (RCT) with 80 participants randomized to receive three doses of 2.7 × 10 6 PfSPZ ( N = 39) or normal saline ( N = 41) just before malaria season. To clear parasitemia, artesunate monotherapy was administered before first and last vaccinations. Thick blood smear microscopy was performed on samples collected during illness and every 4 weeks for 72 weeks after last vaccinations, including two 6-month malaria transmission seasons. Safety outcomes were assessed in all 80 participants who received at least one dose and VE for 79 participants who received three vaccinations. Myalgia was the only symptom that differed between groups. VE (1 − risk ratio; primary VE endpoint) was 38% at 6 months ( P = 0.017) and 15% at 18 months (0.078). VE (1 − hazard ratio) was 48% and 46% at 6 and 18 months ( P = 0.061 and 0.018). Two weeks after the last dose, antibodies to P. falciparum circumsporozoite protein and PfSPZ were higher in protected versus unprotected vaccinees. A three-dose regimen of PfSPZ Vaccine demonstrated safety and efficacy against malaria infection in malaria-experienced adults.

19 November 2023 in Microorganisms
Verified
Journal Article
Open access
PDF file
AHAlimatou Hema
Alimatou Hema
SSSamuel S. Sermé
Samuel S. Sermé
JSJean Sawadogo
Jean Sawadogo
ADAMIDOU DIARRA
AMIDOU DIARRA
ABAissata Barry
Aissata Barry
SSSodiomon Sirima
Sodiomon Sirima
The estimates of enterotoxigenic Escherichia coli (ETEC) and Shigella burden in developing countries are limited by the lack of rapid, accessible, and sensitive diagnostics and surveillance tools. We used a “Rapid LAMP based Diagnostic Test (RLDT)” to detect ETEC and Shigella in diarrheal and non-diarrheal stool samples from a 12-month longitudinal cohort of children under five years of age in a peri-urban area of Ouagadougou in Burkina Faso (West Africa). To allow comparison with the RLDT-Shigella results, conventional culture methods were used to identify Shigella strains in the stool samples. As conventional culture alone cannot detect ETEC cases, a subset of E. coli-like colonies was tested using conventional PCR to detect ETEC toxins genes. Of the 165 stool samples analyzed for ETEC, 24.9% were positive when using RLDT against 4.2% when using culture followed by PCR. ETEC toxin distribution when using RLDT was STp 17.6% (29/165), LT 11.5% (19/165), and STh 8.5% (14/165). Of the 263 specimens tested for Shigella, 44.8% were positive when using RLDT against 23.2% when using culture. The sensitivity and specificity of the RLDT compared to culture (followed by PCR for ETEC) were 93.44% and 69.8% for Shigella and 83.7% and 77.9% for ETEC, respectively. This study indicates that both Shigella and ETEC are substantially underdiagnosed when using conventional culture and highlights the potential contribution of the new RLDT method to improve enteric disease burden estimation and to guide future efforts to prevent and control bacterial enteric infection and disease.

Verified
Journal Article
Open access
PDF file
SOSan M. Ouattara
San M. Ouattara
DODaouda Ouattara
Daouda Ouattara
EBEmilie Salimata Badoum
Emilie Salimata Badoum
ADAMIDOU DIARRA
AMIDOU DIARRA
DHDenise Hien
Denise Hien
SSSodiomon Sirima
Sodiomon Sirima
Continuous monitoring of malaria epidemiology is needed in malaria-endemic settings to inform malaria control and elimination strategies. This study aimed to compare the malariometric indices between the under-fives and school-age children. We surveyed children aged 1.5 to 12 years for plasmodia carriage with the aim of including them in a longitudinal follow-up cohort. The survey took place from 7–11 September 2020 in a southwest area of Burkina Faso. Clinical and demographic data including malaria control measures were collected. A finger prick blood sample was taken for haemoglobin testing, and blood smears and dried blood spot preparation. The malariometric indices were calculated and compared between school-age children and those under the age of five. Multiple logistic regression was fitted to assess the association between malaria parasite carriage and age categories. Based on the PCR results, the parasite prevalence was 21.4% in the under-fives versus 44.2% in school-age children (p-value < 0.0001), with a pooled prevalence of 32.7% (CI = [28.8, 36.8]). The gametocyte prevalence was also significantly higher in school-age children (11.9%) compared to the under-fives (3.7%). Adjusted for covariates, school-age children were 2.9 times (IC = [2.0, 4.2]) more likely to carry the asexual parasite, compared to the under-fives. Malaria was moderate and stable endemic in this area and school-age children play a key role in the spread of the disease. The WHO conditional recommendation for intermittent preventive treatment of malaria in school-aged children living in malaria-endemic settings with moderate to high perennial or seasonal transmission should be implemented.

24 October 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
ESEzinmegnon Sem
Ezinmegnon Sem
NONébié Issa OUEDRAOGO
Nébié Issa OUEDRAOGO
TMTegwen Marlais
Tegwen Marlais
DODaouda Ouattara
Daouda Ouattara
ADAMIDOU DIARRA
AMIDOU DIARRA
SSSodiomon Sirima
Sodiomon Sirima
Background/Objectives: Understanding the seroepidemiology of P. falciparum antibody responses is essential for assessing the acquisition of natural immunity and may guide interventions that impact the acquisition of immunity against malaria in endemic areas. This study assessed the association between antigen-specific IgG responses and protection against P. falciparum infection in children from Burkina Faso. Methods: Children aged 1.5 to 12 years were followed using cross-sectional and longitudinal approaches. IgG responses to 16 P. falciparum antigens were measured using a multiplex assay and analyzed by age group and malaria infection status. Associations between antibody levels and clinical malaria risk were assessed using incidence rate ratios (IRRs), and predictive performance of antibody combinations was evaluated using ROC analysis. Results: IgG responses to AMA1, CSP, and MSP2 CH150 showed weak but significant positive correlation with age. Children aged 5–12 years had higher antibody levels than younger children aged 1.5–5 years. Uninfected children had higher levels of antibodies to EBA181 RIII-V, Rh5.1, and SEA1, while infected children had elevated AMA1 and MSP2 CH150. Anti-GLURP R2 and anti-Rh5.1 antibodies were associated with reduced malaria risk (adjusted IRR = 0.52 and 0.40, respectively). The antibody combination of AMA1, GLURP R2, and Etramp5 Ag1 showed the best predictive performance (AUC = 0.70). Conclusions: This study underlines the value of less-studied antibodies (Etramp5 Ag1, Rh5.1, HSP40 Ag1) for diagnosing and protecting against malaria, opening up prospects for the development of more effective tests and targeted vaccine approaches. The variability of responses according to age and infection status calls for further studies to optimize prevention strategies.

10 October 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
EBEmilie Salimata Badoum
Emilie Salimata Badoum
LKLudovic Kouraogo
Ludovic Kouraogo
ADAMIDOU DIARRA
AMIDOU DIARRA
DODaouda Ouattara
Daouda Ouattara
NONébié Issa OUEDRAOGO
Nébié Issa OUEDRAOGO
SSSodiomon Sirima
Sodiomon Sirima
The aim of this study was to explore molecular measures of P. falciparum malaria burden (FOI and MOI) in the context of seasonal malaria chemoprevention. We analyzed malaria cases collected as part of a longitudinal cohort study. The cohort included P. falciparum-negative children aged 1.5 to 12, as confirmed by PCR 21 days after a radical cure using DHA-PQ or AS. Children were followed up for six months using active and passive case detection methods. At each visit, dried blood spots and blood smears were collected by finger prick, along with clinical data. Parasite DNA was extracted and analyzed by nested PCR for detection and genotyping of P. falciparum parasites. A total of 458 P. falciparum isolates collected during follow-up from October 2020 to March 2021 were genotyped. During the follow-up, children contracted 1.05 (95% IC [0.81–1.30]) new P. falciparum infections/child/time of exposure, and the MOI value was 3.00 (SD 1.60). Age is a protective factor (IRR: 0.74; 95% CI: 0.61, 0.90) against the occurrence of an episode of malaria, unlike an increase in MOI (IRR: 1.63; 95% CI: 1.04, 1.99), which is a favorable factor (p < 0.05). This study confirms the reduction in malaria transmission in our study area, probably due to the massive deployment of control tools.

31 October 2026 in Trends in Public Health
Verified
Journal Article
Open access
PDF file
ADAMIDOU DIARRA
AMIDOU DIARRA
JSJean W. Sawadogo
Jean W. Sawadogo
NONébié Issa OUEDRAOGO
Nébié Issa OUEDRAOGO
AOAlphonse Ouédraogo
Alphonse Ouédraogo
DHDenise Hien
Denise Hien
SSSodiomon Sirima
Sodiomon Sirima
Background: Intestinal parasitic infections are among the most common infections in humans and a major public health problem, affecting around 3.5 billion people, of whom about 450 million develop symptomatic illness and more than 200,000 die each year. Preschool- and school-age children bear much of this burden, and the impact falls disproportionately on people living in low- and middle-income countries (LMICs), where access to health care, safe drinking water and sanitation is limited. This study aimed to determine the prevalence of intestinal parasites, and its variation over time and with age, in children under five years of age in a peri-urban area of Ouagadougou, Burkina Faso, West Africa. Methods: We followed a community-based cohort of children under five years of age in a peri-urban area of Ouagadougou, with stool examinations at enrolment (M0, December 2020-March 2021) and at 6 (M6) and 12 months (M12). The cohort was established to estimate the incidence of shigellosis before a clinical evaluation of the oral shigella vaccine candidate in Burkina Faso. Fresh stool samples were examined by direct microscopy on the day of collection. Changes in prevalence across visits were analysed with generalised estimating equations to account for repeated measurements on the same children. Results: At enrolment, 38.04% (264/694) of children carried at least one intestinal parasite, and 60.1% (440/732) were positive at least once during follow-up. Predominant parasite was Giardia intestinalis, detected in 29.09% of the 1894 stool examinations. Other parasites included Entamoeba genus; Entamoeba histolytica, Hymenolepis nana, Endolimax nana and Isospora belli. Conclusions: Intestinal parasites, mainly Giardia intestinalis, were common in this peri-urban setting, with 33.05% of all stool examinations positive. §Persistence of these parasites across the three visits points denote a permanent reservoir of asymptomatic carriers that must be addressed to interrupt transmission. These results can guide interventions to reduce childhood morbidity and to improve the management of intestinal parasitic infections.